News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
DelsiTech Reveals Significant Licensing Agreement for Innovative Drug Delivery Solution
Friday, May 24, 2024DelSiTech Ltd a company specializing in clinicalstage drug delivery and development has just unveiled a significant milestone Theyve inked a Licensing Agreement with a prominent global pharmaceutical entity
Oxford Nanopore Technologies and Twist Bioscience Partner to Introduce Beta Program for Advancing Personalized Medicine via Pharmacogenomics
Thursday, May 23, 2024Today Oxford Nanopore Technologies announced the launch of a new Pharmacogenomics Beta Program aimed at advancing personalized medicine This program combines Twist Biosciences
Swixx Biopharma Expands into Latin America Through Acquisition and Merger with Biopas
Thursday, May 23, 2024Swixx BioPharma AG a global platform committed to improving access to innovative medicines worldwide has announced its strategic expansion into Latin America The company has finalized
Molecure Granted Approval to Conduct Phase II Clinical Trial for OATD-01 Targeting Pulmonary Sarcoidosis in Specific European Union and Norwegian Regions
Wednesday, May 22, 2024Molecure SA has recently obtained regulatory approvals from several European countries including
Medigene and BioNTech Extend Their Global Research and Collaboration Agreement Beyond the Initially Announced Term
Wednesday, May 22, 2024Medigene AG and BioNTech SE have announced the extension of their collaboration beyond the initial threeyear term outlined in February This extension reflects their commitment to advancing T cell
Qurient Therapeutics and the National Cancer Institute Partner for Phase 1/2 Clinical Trial of Q901 Combined with TROP2-ADC
Wednesday, May 22, 2024Qurient Co Ltd a biotechnology company based in Korea has established a Cooperative Research and Development Agreement with the US National Cancer Institute a part of the National Institutes of Health
AmplifyBio and Xcell Biosciences Collaborate on Manufacturing Solid Tumor-Targeting TCR-T Cell Therapy
Tuesday, May 21, 2024Xcell Biosciences Inc and AmplifyBio have announced a collaborative initiative to enhance the manufacturing process for engineered Tcell receptor therapies targeting solid tumors
Cantex Pharmaceuticals Granted FDA Orphan Drug Status for Azeliragon in Pancreatic Cancer Therapy
Tuesday, May 21, 2024Cantex Pharmaceuticals Inc made an announcement today that the US Food and Drug Administration has granted Orphan Drug Designation to Cantexs azeliragon for treating pancreatic cancer
Virios Therapeutics Prices $1.7 Million Public Offering of Common Stock, Prepares for IMC-2 Long-COVID Phase 2b Study
Monday, May 20, 2024Virios Therapeutics Inc a biotechnology firm focused on developing novel antiviral treatments for chronic illnesses such as fibromyalgia and LongCOVID has disclosed the pricing of its previously
A2 Bio Commences EVEREST-2 Phase 1 Clinical Trial with Initial Patient Administered Novel Mesothelin Logic-Gated CAR T Therapy
Friday, May 17, 2024A Biotherapeutics Inc has initiated the Phase clinical trial for AB marking a significant milestone in the development of its innovative cell therapy This clinicalstage company specializes
